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Abstract
Protein function is often modulated by protein-protein interactions (PPIs) and therefore defining the partners of a protein
helps to understand its activity. PPIs can be detected through different experimental approaches and are collected in
several expert curated databases. These databases are used by researchers interested in examining detailed information on
particular proteins. In many analyses the reliability of the characterization of the interactions becomes important and it
might be necessary to select sets of PPIs of different confidence levels. To this goal, we generated HIPPIE (Human Integrated
Protein-Protein Interaction rEference), a human PPI dataset with a normalized scoring scheme that integrates multiple
experimental PPI datasets. HIPPIE’s scoring scheme has been optimized by human experts and a computer algorithm to
reflect the amount and quality of evidence for a given PPI and we show that these scores correlate to the quality of the
experimental characterization. The HIPPIE web tool (available at http://cbdm.mdc-berlin.de/tools/hippie) allows researchers
to do network analyses focused on likely true PPI sets by generating subnetworks around proteins of interest at a specified
confidence level.
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Introduction
Protein function occurs or is regulated by protein interactions
and therefore knowledge on the partners of a given protein can
give us important information regarding its activity. For instance,
specific protein-protein interactions (PPIs) can be involved in
diseases (see e.g. [1]). PPIs can be evaluated by many experimental
methodologies, which have hugely different degrees of confidence
and different experimental set-ups. For instance, while yeast two
hybrid (Y2H) identifies direct physical interactions between two
proteins, mass spectrometry (MS) based datasets report compo-
nents of protein complexes, which may or may not be in direct
physical contact. In addition to experimental methods, computa-
tional methods propose protein interactions based, for example, on
orthology, protein domains known to interact, co-expression and
functional annotations [2,3].
PPIs are collected in several databases that make the data and
the evidence behind it easily accessible and allow different
mechanisms to query and display the data [4,5,6,7,8,9,10]. These
resources are very useful for researchers interested in checking a
small number of particular proteins of interest. However, PPI data
can also be used globally for systematic network analyses,
prediction of protein properties, and evaluation of novel datasets
of PPIs produced in a high-throughput fashion.
Computational use of PPIdatasets often requires selecting PPIsat
particular levels of confidence. For example, the quality of a novel
PPI dataset may be evaluated by its overlapwithknown interactions
defined with high reliability, whereas a statistical analysis might
require a large number of interactions therefore benefiting from a
less restricted set of PPIs. The flexible selection of PPI datasets at
various confidence levels requires a continuous scoring scheme for
PPIs reflecting the reliability of their experimental characterization.
With the objective of creating a resource allowing the selection
of PPIs by experimental confidence cut-offs, we generated HIPPIE
(Human Integrated Protein-Protein Interaction rEference), a
scored human PPI collection integrated from multiple sources.
Following [8], we developed an expertly curated scoring scheme
that takes into account the reliability of different experimental
evidence in the definition of a PPI combining three types of
information: experimental techniques used, number of studies
finding the PPI, and reproducibility in model organisms.
A web tool to browse the data as well as the scored PPI dataset
are provided at http://cbdm.mdc-berlin.de/tools/hippie. The
scored dataset includes information on the data we used to build
it so that modifications of the scoring mechanism can be easily
achieved. We illustrate the usefulness of HIPPIE in increasing the
coverage of novel PPI datasets and demonstrate that its scoring
scheme reflects the reliability of the reported interactions.
Methods
2.1 Sources
Interactions were retrieved from the following public databases:
BioGRID (version 2.0.62; release date: March 16, 2010) [4], DIP
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date: July 6, 2009) [6], IntAct (release date: March 29, 2010)
[7], MINT (release date: 9 November 2009) [8], BIND (2004
release [11]), and MIPS (published: November 5, 2004) [10].
Genetic interactions were removed from BioGRID. Additionally,
we integrated interactions from manually selected studies
[12,13,14,15,16,17,18,19,20,21,22]; interactions from these studies
were integrated that were not contained in the public databases at
the time of integrating the sources. All resources integrated in
HIPPIE are summarized in Table 1.
Where available, we retrieved the information on the
originating study and the experimental methodology used to
measure each interaction from the source databases and also
assigned an experimental category to interactions from the
additionally included studies. As a result, more than 99% of all
interactions in HIPPIE are associated to at least one of the
methods listed in Table 2 and are annotated with the studies in
which they were detected.
To add to the confidence scoring of experimentally verified
human PPIs a component based on experimental evidence in non-
human organisms we included data from three databases that map
interactions between non-human protein pairs to their human
orthologs: HomoMINT (release date: March 5, 2009) [23], I2D
(release date: January 7, 2010) [2] and the PPI dataset from [24].
2.2 Identifier mapping
Different public PPI databases and datasets use different types of
gene or protein identifiers. We aimed at mapping all protein pairs
listed in HIPPIE to Entrez Gene and UniProt identifiers. For this
purpose we applied the database identifier mapping tables curated by
UniProt [25] and the HUGO Gene Nomenclature Committee
(HGNC) [26]. We mapped all database entries to their canonical
representatives and did not consider splicing forms. In the web
interface the data can be queried either by protein (UniProt id or
accession) or by gene identifier (Entrez Gene id or gene symbol).
Interactions containing identifiers that could not be mapped to
human Entrez Gene ids or UniProt ids were not included in HIPPIE.
Mapping PPIs to the genes encoding the interacting proteins is
affected by certain ambiguity since the same protein sequence may
be encoded by duplicated genomic loci. In the flat file version of
HIPPIE these ambiguous PPIs are expanded such that a given PPI
is represented by all possible combinations of gene identifiers.
2.3 Score calculation
For each interaction a score S between 0 and 1 was calculated
reflecting the reliability of its combined experimental evidence.
This score was calculated as a weighted sum of three different
subscores which are ss (a function of the number of studies in
which an interaction was detected), st (a function of the number
and quality of experimental techniques used to measure an
interaction; see below for details) and so (a function of the number
of non-human organisms in which an interaction was reproduced).
Each of these three subscores si was calculated with a non-linear
saturating function of the form:
si(n)~
2
1ze({ain) {1n
such that si(0)=0 and si(‘)=1, where the ai are constants that
control the steepness of the function.
For subscore ss, n is the number of different studies where the
interaction was reported (number of PubMed identifiers associat-
ed), regardless of whether multiple experimental evidence was
provided in each study.
For subscore so, n is the number of species where orthologs of the
interacting proteins could be defined and were found experimen-
tally to interact (currently Bos taurus, Caenorhabditis elegans, Canis
familiaris, Drosophila melanogaster, Gallus gallus, Mus musculus, Rattus
norvegicus, Saccharomyces cerevisiae, and Sus scrofa).
For subscore st, n is a sum of scores from different experimental
techniques by which an interaction was verified (even if used in the
same study). Most PPI databases use controlled vocabulary
descriptors for these experimental techniques as defined by the
PSI-MI ontology [27], however for someterms we could not find an
equivalent ontology term. Manual curation was used to assign a
score to each PPI detection method ranging from 0 (no experiment
assigned,lessthan 1%of PPIs)to 10.Scoresand correspondingPSI-
MI codes are displayed in Table 2. Methods that can ascertain
interactions with the highest reliability, such as in vitro techniques
like X-ray crystallography, were assigned the highest scores.
Complementation-based assays and affinity based technologies
were roughly equally scored with an average value of 5, slightly
increased for those methods that are used generally in homologous,
more physiological setups, such as FRET. Methodologies that do
not directly provide evidence for interaction, such as colocalization
or cosedimentation, are scored with the lowest values. The total
score S was calculated as a weighted sum of the three subscores:
S~ws  sszwo  sozwt  st
with wszwozwt~1.
It is important to note that our dataset does not include
interactions not experimentally verified with human proteins: no
interaction received a score alone from its verification in non-
human organisms. We also remark that this scoring scheme does
not consider computational evidence other than the definition of
orthology relations from human proteins to proteins in other
organisms.
Table 1. PPI data sources integrated in HIPPIE.
PPI dataset Reference Size
HPRD [6] 40110
BioGRID [4] 30027
IntAct [7] 28073
MINT [8] 14094
Rual05 [19] 6946
Lim06 [17] 5579
Bell09 [13] 3300
Stelzl05 [20] 3232
DIP [5] 1618
BIND [11] 1415
Colland04 [21] 882
Lehner04 [16] 385
Albers05 [12] 290
MIPS [10] 252
Venkatesan09 [22] 239
Kaltenbach07 [15] 227
Nakayama02 [18] 84
HIPPIE 72916
doi:10.1371/journal.pone.0031826.t001
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Technique PSI score Technique PSI Score
3 hybrid method MI:0588 5 footprinting MI:0417 3
acetylation assay 7.5 FRET 6
Affinity Capture-Luminescence 5 gal4 vp16 complementation MI:0728 5
Affinity Capture-MS 5 genetic interference MI:0254 0
Affinity Capture-RNA 2 gst pull down MI:0059 5
Affinity Capture-Western 5 gtpase assay MI:0419 7.5
affinity chromatography technology MI:0004 5 his pull down MI:0061 5
affinity technology MI:0400 5 homogeneous time resolved fluorescence MI:0510 7
anti bait coimmunoprecipitation MI:0006 5 imaging technique MI:0428 1
anti tag coimmunoprecipitation MI:0007 5 in vitro MI:0492 1
antibody array MI:0678 5 in vivo MI:0493 1
array technology MI:0008 3 in-gel kinase assay MI:0423 7.5
atomic force microscopy MI:0872 9 inferred by curator MI:0364 1
beta galactosidase complementation MI:0010 5 ion exchange chromatography MI:0226 3
beta lactamase complementation MI:0011 5 isothermal titration calorimetry MI:0065 10
bimolecular fluorescence complementation MI:0809 6 kinase homogeneous time resolved fluorescence MI:0420 7.5
Biochemical MI:0401 1 lambda phage display MI:0066 6
Biochemical Activity 5 lex-a dimerization assay MI:0369 5
bioluminescence resonance energy transfer MI:0012 6 light microscopy MI:0426 1
Biophysical MI:0013 1 light scattering MI:0067 10
blue native page MI:0276 3 mammalian protein protein interaction trap MI:0231 6
chromatin immunoprecipitation assay MI:0402 2 mass spectrometry studies of complexes MI:0069 5
chromatography technology MI:0091 1 methyltransferase assay MI:0515 7.5
circular dichroism MI:0016 9 methyltransferase radiometric assay MI:0516 7.5
classical fluorescence spectroscopy MI:0017 7.5 molecular sieving MI:0071 2
Co-crystal Structure 10 no experiment assigned 0
Co-fractionation 1 nuclear magnetic resonance MI:0077 10
Co-localization 1 peptide array MI:0081 5
Coimmunoprecipitation MI:0019 5 phage display MI:0084 6
colocalization by fluorescent probes cloning MI:0021 1 phosphatase assay MI:0434 7.5
colocalization by immunostaining MI:0022 1 phosphotransfer assay 7.5
colocalization/visualisation technologies MI:0023 1 polymerization MI:0953 5
comigration in gel electrophoresis MI:0807 3 protease assay MI:0435 7.5
comigration in non denaturing gel electrophoresis MI:0404 3 protein array MI:0089 5
comigration in sds page MI:0808 3 protein complementation assay MI:0090 5
competition binding MI:0405 5 protein cross-linking with a bifunctional reagent MI:0031 5
confocal microscopy MI:0663 1 protein kinase assay MI:0424 7.5
Copurification MI:0025 2 protein tri hybrid MI:0437 5
Cosedimentation MI:0027 2 Protein-peptide 5
cosedimentation in solution MI:0028 2 Protein-RNA 0
cosedimentation through density gradient MI:0029 2 pull down MI:0096 2.5
cross-linking study MI:0030 5 pull-down/mass spectrometry 5
deacetylase assay MI:0406 7.5 Reconstituted Complex 10
demethylase assay MI:0870 7.5 reverse phase chromatography MI:0227 1
dihydrofolate reductase reconstruction MI:0111 6 reverse two hybrid MI:0726 5
dynamic light scattering MI:0038 9 ribonuclease assay MI:0920 7.5
electron microscopy MI:0040 5 saturation binding MI:0440 7.5
electron paramagnetic resonance MI:0042 9 scintillation proximity assay MI:0099 7.5
electron tomography MI:0410 9 solid phase assay MI:0892 1
electrophoretic mobility shift assay MI:0413 2 surface plasmon resonance MI:0107 10
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The six free parameters of the scoring formula (as, ao, at, ws, wo and
wt) were optimized by performing a grid search in the parameter
space. We performed the search in the range [0, 3] for the ai and in
the range [0, 1] for the wi. We chose a step width of 0.1 for both ai
and the wi. The step width was chosen sufficiently small such that
selecting neighboring parameter combinations resulted only in small
changes in the interaction scores which decreased the probability of
missing an optimal solution. Constraints were set on the weights wi
by requiring that they sum up to 1. Parameter combinations leading
to only few discrete scores were excluded (this happened, for
example, when wt was set to 0, since the different experimental
weights account for a large fraction of the score’s granularity).
PPIs are sometimes reported in multiple studies. We reasoned
that we could use this property to assess the performance of a
parameter combination. To do this evaluation we used the IntAct
dataset, which currently consists of 28 073 interactions (38.5% of
HIPPIE). This dataset has explicit associations between studies
and experiments, and the experimental information is annotated
following the PSI-MI format.
The assessment of performance of a parameter set was done by
successively removing each one of the 109 studies in IntAct that
contain at least 10 interactions and more than two PPIs found in
multiple studies. For each study j, we recalculated the scores of the
remaining dataset, IntActred, found the set of PPIs described both
in the study j and in IntActred, IntActred\studyj
  
, and
computed the deviation from random expectation of the number
of highly scored interactions among the overlap:
devj~
scores IntActred\studyj
  
wQ3
       
IntActred\studyj
       
0:25
where Q 3 is the upper quartile of the score distribution of IntActred.
To measure the overall performance of a parameter combina-
tion we chose a function f of the weighted mean of the logarithm of
devi over all studies:
f~
P
j vj  log2devj
n
where the weights vi were chosen proportional to the overlap size
between IntActred and studyj and n is the number of studies. The
best parameter combination maximizes f.
We found several parameter combinations (several thousand
optimal combinations out of more than 700 000 different
parameter combinations tested) maximizing the function f
(max(f)=1.023). From the equally well performing parameter
combinations we chose the set of parameters that resulted in the
largest spread of the distribution of scored interactions. For that
purpose the scores of the entire HIPPIE were repeatedly
calculated for each of the optimal parameter combination and
for each score distribution the interquartile range (iqr) was
determined. We found that the parameter set [as=2.3, ao=1.6,
at=0.2, ws=0.6, wo=0.1, wt=0.3] maximized both f and iqr.
Results
HIPPIE is a dataset of experimentally measured human PPI
derived from several publicly available PPI datasets (Table 1). For
reference, we distribute a stable release of HIPPIE consisting of
72 916 interactions, which was used in this manuscript for several
descriptive analyses (Table S1; HIPPIE version 1.2). The live version
ofHIPPIEismonthlyupdatedmakinguseofthewebqueryinterface
PSICQUIC [28], which allows us to automatically retrieve the
newest interaction data from most of the manually curated source
databases (BioGrid, IntAct, MINT, DIP and BIND) and integrate
the new interactions and updated evidence records into HIPPIE.
The network is accessible via a web tool (http://cbdm.mdc-
berlin.de/tools/hippie) that allows for querying the interactions by
a gene symbol, Entrez gene id or UniProt identifier (id and
accession). On the result page a confidence score is listed with each
interaction partner of the query protein and detailed information
on the evidence contributing to the confidence score can be
accessed. Links to the original studies are provided.
A typical problem after generation of experimental results
producing a list of genes, proteins and/or interactions between
them, is the evaluation of the results in relation to the known PPI
data. For example, a researcher may have obtained proteomics
data for a few proteins of interest and wants to evaluate the novelty
of the interactions, or the possible relation of the interactors with a
disease protein of interest.
Technique PSI score Technique PSI Score
electrophoretic mobility supershift assay MI:0412 2 t7 phage display MI:0108 6
enzymatic study MI:0415 1 tandem affinity purification MI:0676 5
enzyme linked immunosorbent assay MI:0411 5 tox-r dimerization assay MI:0370 5
experimental interaction detection MI:0045 1 transcriptional complementation assay MI:0232 5
far western blotting MI:0047 5 transmission electron microscopy MI:0020 5
filamentous phage display MI:0048 6 two hybrid fragment pooling approach MI:0399 5
filter binding MI:0049 5 Two-hybrid MI:0018 5
fluorescence correlation spectroscopy MI:0052 10 ubiquitin reconstruction MI:0112 5
fluorescence microscopy MI:0416 1 x ray scattering MI:0826 9
fluorescence polarization spectroscopy MI:0053 10 x-ray crystallography MI:0114 10
fluorescence technology MI:0051 1 x-ray fiber diffraction MI:0825 9
fluorescence-activated cell sorting MI:0054 1 yeast display MI:0115 5
fluorescent resonance energy transfer MI:0055 6
doi:10.1371/journal.pone.0031826.t002
Table 2. Cont.
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proteins and/or interactions between them from which a network
of known data around the proteins of interest is constructed. The
online tool will identify interactions between the proteins
submitted (layer 0 network), or their interactors not contained in
the query set (layer 1 network). The computation of networks with
more layers might be lengthy if hundreds of protein partners have
to be analysed. For this we provide a Java command line tool
(available from http://cbdm.mdc-berlin.de/tools/hippie and also
deposited at the SourceForge open software archive: https://
sourceforge.net/projects/hippiecbdm) that will do the computa-
tion on the local machine of the user for large input sets or
neighbours of neighbours. A confidence threshold to control the
reliability and size of the constructed network can be also applied.
Additionally, we provide a filter option for the PSI-MI interaction
type annotation provided by most of HIPPIE’s source databases.
This feature allows for selecting direct physical interactions from
HIPPIE. The thereby generated HIPPIE subnetworks can be
exported from HIPPIE for further analyses or can be visualized
using the tool Cytoscape Web [29], which has been integrated into
HIPPIE.
The web site also offers the entire HIPPIE dataset for download
in two different formats: in PSI-MI TAB 2.5 format as defined by
the Protein Standard Initiative [27] and in our own tab delimited
flat file format. Currently we distribute a freeze version (version
1.2) used in this manuscript for analyses, and the monthly updated
version.
While merging the different data sources we kept track of the
information about which experimental system type was used to
detect each single interaction and whether there were several
studies where the interaction was found. Additionally we retrieved
the interaction data from PPI databases that link interactions in
non-human model organisms to their human orthologs. From
these different types of information (experimental systems, number
of studies and reproducibility in other organisms) we calculated an
overall score reflecting the reliability of each interaction (See
Methods for details and Table 2).
We note that the different experimental methodologies behind
the PPIs in HIPPIE are able to detect direct physical interactions
between proteins to a varying degree. Even though some of them
are in fact measuring co-membership in larger protein-complexes
we will refer to all types of associations detected by these methods
as interactions or PPIs. The HIPPIE score tries to reflect both the
reliability of the various methods as well as the ability to detect
direct rather than indirect interactions.
The number of PPIs derived from different experimental system
types was very variable. HIPPIE integrates various datasets dealing
with different experimental systems and thus contains a larger
amount of interactions than each of those sets separately (Table 1).
Values for three well populated and meaningful sources of PPIs,
Y2H, anti-bait coimmunoprecipitation (Coprep), and tandem
affinity purification (TAP) are shown in Figure 1 that cover 78% of
the total amount of proteins in the current version of HIPPIE, but
only around 50% of its interactions. Coprep and TAP share
relatively many PPIs between each other (139 PPIs) compared to
the other pairwise overlaps between methods. For example, TAP
shares 95 interactions with Y2H despite the much higher amount
of Y2H interactions as compared to Coprep. This higher overlap
between Coprep and TAP in comparison with the Y2H data
might reflect the similarity between the first two approaches in
comparison with the latter, as Coprep and TAP are both based on
antibody capture of a protein complex while Y2H is based on the
reconstitution of a binary interaction inside of a heterologous
system (yeast).
To illustrate the benefit of using a large dataset such as HIPPIE,
we compared it with novel high-throughput PPI datasets not used
for its production. We chose two high-throughput PPI datasets
from the recent literature: a Y2H dataset, Y2He [30], containing
551 PPIs between 434 proteins and a MS dataset, MSe [31],
containing 711 PPIs between 424 proteins. The coverage of the
Y2He and MSe datasets by HIPPIE was of 120 (21.8%) and 73
(10.3%) PPIs, respectively.
We evaluated the usefulness of the HIPPIE score using the two
novel datasets. The HIPPIE database was divided in a high quality
Figure 1. Coverage of HIPPIE and overlap by three technique specific datasets. Left: proteins. Right: PPIs. Y2H is yeast-two-hybrid, Coprep
is anti-bait coimmunoprecipitation and MS is affinity capture mass spectrometry. The protein numbers show that Y2H can focus on many proteins
that have not been targeted by the other two techniques. Together the three techniques already cover 80% of all proteins currently considered in
HIPPIE (i.e. 80% of all proteins in HIPPIE participate in at least one Y2H, Coprep or MS experiment). However, the overlap in PPIs between these
datasets and to the remainder of HIPPIE is much smaller indicating that PPI detection is technique specific. Nevertheless, one can appreciate that
similar techniques have a bias towards detecting similar PPIs, here illustrated by the significant overlap between Coprep and MS and by the little
overlap of Y2H to the other two techniques.
doi:10.1371/journal.pone.0031826.g001
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.=0.73) and a lower quality subset (score ,0.73; see Figure 2).
Then, we compared the fraction of PPIs in each HIPPIE subset
that was recalled by the novel dataset. If the scores are meaningful
one would expect better recall of the set with high-confidence
scores.
To measure the recall of HIPPIE by an external dataset of PPIs
one has to consider that some HIPPIE PPIs may not be detectable
by the experimental setup used to produce the external dataset. In
the case of Y2H and MS datasets a number of proteins are used as
baits. Therefore, we considered for each of these studies that the
‘‘detectable PPIs’’ from HIPPIE were those where at least one of
the interacting proteins was a bait in the study considered
(Table 3). The values of detectable PPIs and recall were used to
calculate one-sided Fisher’s exact tests to assess the significance of
the differences in recall between high and low confidence HIPPIE
subsets. The high quality subset had the largest overlaps in
percentage with the PPIs of the novel datasets and these overlaps
were significant (Table 3; p-values of 6.40e-15 and 1.75e-6 for
Y2He and MSe, respectively) suggesting that the PPI score
correlates with experimental reproducibility.
Discussion
In this work we presented HIPPIE, an integrated dataset of
human protein interaction data scored according to experimental
evidence. This resource has been created for those researchers that
need to use globally the complete knowledge on human protein
interactions. This is required in systems biology studies and in the
evaluation of high-throughput results (e.g. novel PPI datasets) that
require contrasting results with interactions selected for a
particular level of reliability.
HIPPIE currently integrates 72 916 interactions from several
public PPI resources scored according to confidence. For
comparison, the complete human interactome map has been
estimated to contain between 200 000 and 400 000 interactions
(according to [32] and [33], respectively) suggesting that our
knowledge of the human interactome is still incomplete.
Figure 2. Distribution of HIPPIE confidence scores. Interactions with scores above 0.73 (black bars) constitute only 25% of all and could be
considered high-confidence interactions. According to the design of the scoring function, such score implies that the interaction is supported by
multiple evidence.
doi:10.1371/journal.pone.0031826.g002
Table 3. Coverage of HIPPIE by novel datasets.
HIPPIE subset HIPPIE subset size Y2He MSe
detectable
PPIs
Overlap PPIs
(recall)
detectable
PPIs
Overlap PPIs
(recall)
score .=0.73 18592 2239 75 (3.3%) 322 41 (12.7%)
score ,0.73 54324 5760 45 (0.8%) 806 32 (4.0%)
doi:10.1371/journal.pone.0031826.t003
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critical for its usability because novel high-throughput PPI datasets
often contain just hundreds of PPIs and might have little overlap
with smaller existing PPI resources integrated in HIPPIE.
Several resources have been created that, like HIPPIE, integrate
PPI data from multiple sources but do not have a focus on
distributing a simple scored dataset, while offering excellent tools
to examine evidence behind each PPI (e.g. iRefWeb [34]) or do
not focus on experimentally verified interactions (e.g. STRING
[35]). Some other databases offer a continuous confidence scoring
scheme, e.g. MINT [8] and HAPPI [36], but they do not allow
batch scoring of PPI sets or the exclusive retrieval of high
confidence interactions and lack the integration of several
important high-throughput experimental datasets. The scoring
system of MINT is closer to the one we use as it considers levels of
technical evidence, number of studies and orthology [8]; however,
as the PPI data from MINT is manually curated, the amount of
human PPIs in MINT is currently less than a third of those in
HIPPIE, limiting its use in the evaluation of novel datasets. Finally,
in contrast with MINT and HIPPIE, HAPPI contains only a small
fraction of PPIs experimentally derived in human while the
majority are either computationally predicted or inferred from
other species.
We are aware that any assignment of reliability scores to
experimental techniques necessarily reflects the individual belief of
researchers. We tried however to base our selection of parameters
and weights in the scoring formula on objective criteria by
optimizing the performance of our scoring scheme in assigning high
values to reproducible interactions. For researchers who nevertheless
wish to modify either the selected parameters or the scores assigned
to the different techniques we offer a tool at our homepage that
allows the scoring of HIPPIE using an altered set of these values.
HIPPIE has been used for the evaluation of existing novel PPI
datasets showing that it increases their coverage over individual
resources and that its scoring scheme correlates with the ability to
find a PPI in experimental data not included in the database
(Table 3). A web tool to query the data, the scored PPI dataset as
well as the raw data are available at http://cbdm.mdc-berlin.de/
tools/hippie. The tool allows batch annotation of datasets of PPIs.
Future work on HIPPIE will be directed towards the inclusion of
novel datasets and versions for major model organisms.
Supporting Information
Table S1 Scored dataset of PPIs. The columns indicate (1)
UniProt identifier and (2) Entrez Gene identifier of the first protein
partner, (3) UniProt identifier and (4) Entrez Gene identifier of the
second protein partner, (5) score and (6) a comment field
summarizing the origin of the evidence. Evidence is arranged in
three types: experiments, pmids, and sources. Experiment types
are indicated in Table 2. Pmids are the PMID of manuscripts
reporting the interaction. Sources are the datasets where the
interaction was found and are indicated in Table 1. Multiple
evidences for each type are separated by semicolon and multiple
evidence codes for each type are separated by comma. If one
protein maps to several genes, each combination of genes is listed
in a separate line. This table is available from: http://cbdm.mdc-
berlin.de/tools/hippie/hippie_v1_2.txt.
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